Multiple myeloma trials in Saudi Arabia
2 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Where
- Riyadh
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06615479EU 2024-515279-37-00Registry updated 2026-10-29
Phase 3RecruitingTrial-stage medicine
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
- Where
- Riyadh
- Age
- 18 years to 130 years
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07735637Registry updated 2026-10-21
All Multiple myeloma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.